BioNexus Gene Lab (BGLC) announced a strategic partnership with ML Tech to optimize the BGLC’s Ethereum-based growth ...

Medical technology company BioNexus Gene Lab Corp. (NASDAQ:BGLC) announced the adoption of Ethereum (CRYPTO: ETH) as ...

The tech firm will prioritize Ethereum over Bitcoin as a strategic asset, touting the asset's potential as a "financial ...

BioNexus Gene Lab Corp. (NASDAQ: BGLC), a technology company dedicated to innovation in the digital and healthcare space, has announced a strategic partnership with ML Tech to optimize the BGLC’s ...

BioNexus Gene Lab Corporation, a leading medical laboratory services provider, has made history by becoming the first ...

To provide transparency and further insight into this decision, BGLC has published its Ethereum Strategy Whitepaper, which is now available to the public. This document outlines Ethereum’s role as a ...

BioNexus Gene Lab board of directors has officially approved the Ethereum-focused treasury strategy, alongside an ETH ...

Ethereum has been chosen over Bitcoin as a medical firm's treasury asset. The firm cited staking, DeFi, dApps, and other ...

BTC rallies on tariff delay & conference optimism. BTC sentiment still in ‘Extreme Fear’. Coinbase plans to offer tokenised securities. New Hampshire BTC bill passes House committee. Falling USD ...

KUALA LUMPUR, Malaysia, March 06, 2025 (GLOBE NEWSWIRE) -- BioNexus Gene Lab Corp. (NASDAQ: BGLC), a technology company dedicated to innovation in technology and healthcare, is pleased to announce ...

KUALA LUMPUR - BioNexus Gene Lab Corp. (NASDAQ: BGLC), a Nasdaq-listed technology company in the healthcare sector with a market capitalization of $5.88 million and annual revenue of $9.26 million ...

Ethereum [ETH] ETF flows turned positive after 10 days of an outflow trend, signaling a likely renewed demand for the altcoin ...